These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 7941918

  • 21. A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine.
    Cappuccio FP, Markandu ND, Singer DR, Buckley MG, Miller MA, Sagnella GA, MacGregor GA.
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):297-302. PubMed ID: 1829368
    [Abstract] [Full Text] [Related]

  • 22. Treatment of hypertension with a fixed ratio combination of long-acting propranolol and bendrofluazide, and influence of age of the subject.
    Herrick AL, Davis JM, Weir RJ.
    Br J Clin Pract; 1989 Jun; 43(6):196-200. PubMed ID: 2597598
    [Abstract] [Full Text] [Related]

  • 23. Impact of antihypertensive treatment on quality of life: comparison between bisoprolol and bendrofluazide.
    Vanmolkot FH, de Hoon JN, van de Ven LL, Van Bortel LM.
    J Hum Hypertens; 1999 Aug; 13(8):559-63. PubMed ID: 10455479
    [Abstract] [Full Text] [Related]

  • 24. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J, Neveux E, Blondin P.
    J Int Med Res; 1995 Aug; 23(4):244-53. PubMed ID: 7589767
    [Abstract] [Full Text] [Related]

  • 25. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR, Weber MA, Punzi HA, Serfer HM, Rosenblatt S, Cady WJ.
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [Abstract] [Full Text] [Related]

  • 26. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I, Saruta T, ADVANCE-Combi Study Group.
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [Abstract] [Full Text] [Related]

  • 27. New sustained-release nifedipine formulation in treatment of essential hypertension. Unidipin Cooperative Study Group.
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):349-53. PubMed ID: 1378112
    [Abstract] [Full Text] [Related]

  • 28. Controlled trial of nifedipine and bendroflumethiazide in hypertension.
    Hallin L, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1983 Mar; 5(6):1083-5. PubMed ID: 6196558
    [Abstract] [Full Text] [Related]

  • 29. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B, Johnston GD.
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [Abstract] [Full Text] [Related]

  • 30. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
    Fermé I, Djian J, Tcherdakoff P.
    J Cardiovasc Pharmacol; 1990 Jul; 16 Suppl 1():S46-50. PubMed ID: 1706014
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC, Haggert BE, Liss C.
    Clin Ther; 1994 Jul; 16(4):634-46. PubMed ID: 7982251
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Jul; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
    Glasser SP, Neutel JM, Gana TJ, Albert KS.
    Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-acting diltiazem CD is safe and effective in a hypertensive Mexican-American population.
    Herrera CR, Lewin A, Fiddes R, Friedman J, Linn W, Baker T, Balanoff D, Beach CL.
    Pharmacotherapy; 1997 Jan; 17(6):1254-9. PubMed ID: 9399608
    [Abstract] [Full Text] [Related]

  • 40. The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials.
    Bulpitt CJ, Fletcher AE, Amery A, Coope J, Evans JG, Lightowlers S, O'Malley K, Palmer A, Potter J, Sever P.
    Drugs Aging; 1994 Sep; 5(3):171-83. PubMed ID: 7803945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.